Inflammation plays a critical role in the response to and survival from injuries and/or
infections. It occurs in two phases: initiation and resolution; however, when these events do …

The protozoan Trypanosoma cruzi is the causative agent of Chagas disease, one of the
world's major neglected infections. Although development of improved antiparasitic drugs is …

The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public
health problem throughout Latin America. Current therapeutic options are characterised by …

The insect-transmitted protozoan parasite Trypanosoma cruzi is the causative agent of
Chagas disease, and infects 5–8 million people in Latin America. Chagas disease is …

Chagas disease is caused by infection with the insect-transmitted protozoan Trypanosoma
cruzi, and is the most important parasitic infection in Latin America. The current drugs …

Specific chemotherapy using benznidazole (BNZ) for Chagas disease during the chronic
stage is controversial due to its limited efficacy and toxic effects. Although BNZ has been …

Infectious myocarditis is the result of an immune response to a microbial infection of the
heart. The blood vessels of the heart, both the intramyocardial microvasculature and the …

Background Chagas disease (CD) is caused by Trypanosoma cruzi and affects 6–7 million
people worldwide. Approximately 30% of chronic patients develop chronic chagasic …

Chagas disease, caused by Trypanosoma cruzi, is the main cause of dilated
cardiomyopathy in the Americas. Antiparasitic treatment mostly relies on benznidazole (Bzl) …

Background Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and is
a serious public health problem throughout Latin America. With 6 million people infected …